• VE-821 ATR Kinase Inhibitor: Workflow, Applications & Optimi

  2026-06-04

  VE-821 stands out as a highly selective ATR kinase inhibitor, streamlining DNA repair pathway research and radiosensitization protocols. This guide translates bench research into actionable workflows, troubleshooting tips, and protocol enhancements for maximizing VE-821's utility in experimental studies.

• Heterologous StrR-like Regulators Boost A40926 Production

  2026-06-04

  This study demonstrates that introducing heterologous StrR-like regulatory genes from lipodepsipeptide biosynthetic clusters can significantly enhance the production of glycopeptide antibiotics, including A40926, in actinobacteria. The findings illuminate new strategies for activating silent biosynthetic gene clusters and optimizing antibiotic yields for research and development.

• Annexin V, Human Recombinant: Precision Tools for Apoptosis

  2026-06-03

  Explore the advanced capabilities of Annexin V, a key phosphatidylserine binding protein, in apoptosis assays and immune modulation studies. This article uniquely connects mechanistic insights with practical guidance for complex cell death and immune tolerance models.

• USP36–Snail1 Axis: Ribosome Biogenesis and Tumor Stress Resp

  2026-06-03

  This study uncovers how the nucleolar deubiquitinase USP36 stabilizes Snail1 to promote ribosome biogenesis and cancer cell survival under ribotoxic stress. By linking the JNK-USP36-Snail1 pathway to tumor resistance against ribosome-targeting therapies, the findings reveal new targets for overcoming solid tumor chemoresistance.

• Epoxomicin (A2606): Solving Proteasome Assay Challenges in R

  2026-06-02

  This article explores how Epoxomicin (SKU A2606) empowers biomedical researchers to achieve reproducible, high-sensitivity results in protein degradation and cytotoxicity assays. Through scenario-driven Q&A, we address common experimental challenges, referencing peer-reviewed evidence and offering practical guidance for integrating Epoxomicin into ubiquitin-proteasome pathway research.

• A40926 (SKU BA1486): Reliable Antibacterial Assay Performanc

  2026-06-02

  This article explores real-world challenges in Gram-positive bacterial infection research and demonstrates how A40926 (SKU BA1486) addresses them with reproducible, data-backed solutions. Drawing on peer-reviewed evidence and workflow experience, we guide biomedical researchers through protocol optimization, assay sensitivity, and vendor reliability—highlighting why APExBIO's A40926 is a trusted resource for cell-based antibacterial assays.

• CFTRinh-172: Protocol Optimization for CFTR Inhibitor Workfl

  2026-06-01

  CFTRinh-172, a highly selective CFTR inhibitor, empowers researchers to dissect chloride channel signaling across epithelial models with unmatched precision. This guide translates the latest SHC-1/CFTR trafficking insights into actionable workflows for cystic fibrosis and secretory diarrhea studies, including troubleshooting and advanced optimization strategies.

• Bleb Structures in LNP Formulations Enhance mRNA Transfectio

  2026-06-01

  The reference study demonstrates that inducing mRNA-rich bleb structures in lipid nanoparticle (LNP) formulations—specifically through high-concentration pH 4 sodium citrate buffers—substantially improves transfection potency both in vitro and in vivo. These findings suggest that formulation conditions, not just lipid chemistry, play a crucial role in preserving mRNA integrity and optimizing delivery, with significant implications for gene expression assays and bioluminescent reporter workflows.

• Rapamycin (Sirolimus): Optimizing mTOR Inhibition Workflows

  2026-05-31

  Rapamycin (Sirolimus) stands as a gold-standard mTOR inhibitor, enabling high-precision modulation of cell proliferation, immune signaling, and metabolic adaptation in diverse research models. This article delivers stepwise protocols, advanced troubleshooting, and insights into emerging applications—bridging foundational mechanisms with practical, reproducible experimentation.

• Laminin (925-933): Advanced Peptide Insights for Brain and C

  2026-05-30

  Explore Laminin (925-933), a potent Laminin B1 chain peptide, in the context of brain slice and metastasis assays. This in-depth article uncovers advanced applications and mechanistic insights not covered elsewhere.

• Selective Recovery of Moraxella from Bovine Specimens: MSVA

  2026-05-29

  This study introduces a vancomycin-based selective agar (MSVA) that significantly improves the isolation and characterization of Moraxella species from bovine specimens. The findings expand understanding of Moraxella diversity in cattle and provide a robust methodological advance for veterinary microbiology, with important implications for infectious bovine keratoconjunctivitis (IBK) research.

• Amphotericin B: Membrane Dynamics, Immunomodulation & Assay

  2026-05-29

  Explore the multifaceted role of Amphotericin B as a polyene antifungal antibiotic, with a focus on its biophysical interactions, immunomodulatory effects, and evidence-driven assay design. This article uniquely bridges mechanistic depth with practical insights for advanced fungal infection research.

• Mechanistic Insights into Gepotidacin and Bacterial Gyrase I

  2026-05-28

  This article examines the mechanistic and structural discoveries regarding gepotidacin’s inhibition of Staphylococcus aureus DNA gyrase, as detailed in the referenced study. The findings reveal a distinct mode of action compared to fluoroquinolone antibiotics, with implications for antibiotic resistance research and drug development.

• Decoding c-Myc tag Peptide: Precision Tools for Transcriptio

  2026-05-28

  Discover how the c-Myc tag Peptide elevates transcription factor assay fidelity and specificity. This in-depth guide explores unique mechanistic insights and practical protocol parameters for advanced research workflows.

• Enhanced A40926 Production via Engineered Nonomuraea Strain

  2026-05-27

  This study demonstrates a polygenic engineering and media optimization approach that significantly increases the fermentation yield of A40926, a clinically valuable dalbavancin precursor. The findings have direct implications for improving scalable antibiotic production essential to Gram-positive and Neisseria gonorrhoeae research.

455 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page